The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity
about
cAMP-responsive element modulator (CREM)α protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosusImmunodeficiency and autoimmunity: lessons from systemic lupus erythematosusPleiotropic Effects of IL-2 on Cancer: Its Role in Cervical CancerAntigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 DiabetesCytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus ErythematosusInflammatory cytokines in systemic lupus erythematosusFollicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cellsNKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter.IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cellsCellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms.Lupus-prone mice fail to raise antigen-specific T cell responses to intracellular infectionTranscriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus.Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.The dysregulation of cytokine networks in systemic lupus erythematosus.T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.Estrogen upregulates cyclic AMP response element modulator α expression and downregulates interleukin-2 production by human T lymphocytesCalcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupusEngagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosusA systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report.CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalanceMicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis.The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases.T cells and IL-17 in lupus nephritis.The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients.Function and regulation of microRNA-31 in development and disease.Low-Dose IL-2 in the Treatment of Lupus.Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.A 33D1+ Dendritic Cell/Autoreactive CD4+ T Cell Circuit Maintains IL-2-Dependent Regulatory T Cells in the Spleen.Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon ActivityAn era of biological treatment in systemic lupus erythematosus.Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy.Systemic lupus erythematosus.Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease.Regulatory T Cells As Supporters of Psychoimmune Resilience: Toward Immunotherapy of Major Depressive Disorder.A Distinct T Follicular Helper Cell Subset Infiltrates the Brain in Murine Neuropsychiatric Lupus.
P2860
Q24339465-C4747808-687C-47DD-846B-C43C135D087BQ24632664-EFC80E00-C06F-4399-8EFA-263E70126ACBQ26747008-E382FC46-B49D-409F-BD38-720E4CDE3784Q26770386-3EDE7C27-614F-4A6B-899A-71EF868F20F2Q26782454-8AF5D2EC-FE41-45C1-AAD0-4844047E3AA8Q26823647-A8C83625-83A1-446F-B97F-D1FCE8944F22Q28067781-706D1061-AAC6-4A09-9ADA-547D8FD32ACCQ28303160-544FA1E8-8E38-48FF-A9F0-EC0D02E2DA24Q33816779-9EED9CF8-A1F7-4490-B22B-05B9EDEDE0CFQ34049838-E3B40B6A-56A2-4693-91D6-1D9E75EBB5A0Q34053939-99F1E6C4-C5CF-4C95-B090-42E222AF658FQ34374089-A46EC916-8D8F-4F5C-BEFE-0E88B28BF681Q34435073-BBCFB8FF-B3E8-4ED0-9CCA-4E1FCAA6DD6BQ34503070-348AEF57-C3A7-4168-B4B3-BAEA374E490BQ34901832-6FEC56D6-3766-4575-AD73-B390009761E8Q35294513-C6966A6B-5C1F-41F6-BEF3-E3369F2B0CABQ35836112-C497A8E1-8776-44F8-B2E9-B22AFC5BA0D5Q35973283-A1718831-393B-41EA-9D6B-9357A2EC2F3BQ36252570-BD131EE6-3D43-4880-ADEA-FBFBE1317FD6Q37200094-D027AA4A-C785-4B9F-A4E4-8B3A3F74507CQ37433446-8C43F1A4-B8C7-45C2-A78E-D2B1028AA7F8Q37726675-64D1E1A8-6EA8-4768-8DA4-0EECF0C71715Q38052464-D4A8A2CB-AB72-4BB5-9060-EC8E9789DD26Q38424758-BA5E6F61-3C02-4B2A-91C5-D746E9711D94Q38816316-32FA766E-2ACF-429D-8E00-3698D7194CFBQ38873595-314A7574-4B72-4DE6-A8EF-BE0822E85A00Q38893973-4B34ABBE-6863-4B8C-B2FC-24B91E5DBF76Q38979253-7A30656A-2AA3-4102-B8A4-C895E7563CE5Q39088684-7FE60386-0821-4292-8790-D36B0CA1B405Q40656321-DC829B0F-0C75-42BC-8796-F522DFB744ABQ41648555-C590F576-022A-4970-9951-58CB1F83AD84Q41692822-D1DE7C7F-83E5-424E-8EFB-6AA7BAFFAFD1Q48128911-8B57A5CC-20C3-4236-8362-5E50B9551080Q50068095-6DB994CF-93A9-4837-9149-74AA39929BCDQ50848358-D902442C-E532-4A14-9688-4804604A23B8Q50940528-AA771E8D-BD5B-4953-8FDA-EA3DD6F0E62AQ51039411-01E55D8D-1314-4331-9AFA-43205D97AF5AQ52316320-E9B2D881-6C7F-44F9-95B8-298381608149Q52608611-ED193ACB-0434-46DE-995D-981B51DEC9A3Q52723423-B52EDD9C-8E18-4544-8EF8-E16A2C2A5E14
P2860
The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The IL-2 defect in systemic lu ...... ansive effect on host immunity
@ast
The IL-2 defect in systemic lu ...... ansive effect on host immunity
@en
type
label
The IL-2 defect in systemic lu ...... ansive effect on host immunity
@ast
The IL-2 defect in systemic lu ...... ansive effect on host immunity
@en
prefLabel
The IL-2 defect in systemic lu ...... ansive effect on host immunity
@ast
The IL-2 defect in systemic lu ...... ansive effect on host immunity
@en
P2860
P356
P1476
The IL-2 defect in systemic lu ...... ansive effect on host immunity
@en
P2093
George C Tsokos
Linda A Lieberman
P2860
P304
P356
10.1155/2010/740619
P577
2010-06-06T00:00:00Z